These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


617 related items for PubMed ID: 1035504

  • 1. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M, Bolan G, Huff K.
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [Abstract] [Full Text] [Related]

  • 2. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M, Bolan G, Huff K.
    Cancer Res; 1976 Dec; 36(12):4595-601. PubMed ID: 1000504
    [Abstract] [Full Text] [Related]

  • 3. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK, Boldt DH, Estrada P.
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [Abstract] [Full Text] [Related]

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 5. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [Abstract] [Full Text] [Related]

  • 6. Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M, Monaco ME, Bolan G.
    Cancer Res; 1977 Jun; 37(6):1901-7. PubMed ID: 870192
    [Abstract] [Full Text] [Related]

  • 7. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

  • 8. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells.
    Welsh TH, Jia XC, Jones PB, Zhuang LZ, Hsueh AJ.
    Endocrinology; 1984 Oct; 115(4):1275-82. PubMed ID: 6434288
    [Abstract] [Full Text] [Related]

  • 9. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 10. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB, Kelsey WH, Goran N.
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [Abstract] [Full Text] [Related]

  • 11. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS.
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [Abstract] [Full Text] [Related]

  • 12. Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig.
    Gulino A, Pasqualini JR.
    Cancer Res; 1980 Oct; 40(10):3821-6. PubMed ID: 7438065
    [Abstract] [Full Text] [Related]

  • 13. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P, Lykkesfeldt AE.
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [Abstract] [Full Text] [Related]

  • 14. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC, Katzenellenbogen BS.
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [Abstract] [Full Text] [Related]

  • 15. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C, Hollander C, Miller B.
    Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
    [Abstract] [Full Text] [Related]

  • 16. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ, Nelson K, Srinivasan S, Powell DE, Kenady DE, DePriest PD, Gallion HH, van Nagell JR.
    Cancer Res; 1992 Aug 01; 52(15):4106-12. PubMed ID: 1638522
    [Abstract] [Full Text] [Related]

  • 17. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK, Hobbs K, Clark GM.
    Cancer Res; 1985 Feb 01; 45(2):584-90. PubMed ID: 3967234
    [Abstract] [Full Text] [Related]

  • 18. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.
    Reddel RR, Murphy LC, Sutherland RL.
    Cancer Res; 1983 Oct 01; 43(10):4618-24. PubMed ID: 6883318
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E, Borgna JL, Rochefort H.
    Cancer Res; 1982 Jan 01; 42(1):317-23. PubMed ID: 7053859
    [Abstract] [Full Text] [Related]

  • 20. The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells.
    Strobl JS, Monaco ME, Lippman ME.
    Endocrinology; 1980 Aug 01; 107(2):450-60. PubMed ID: 7389663
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.